Back to Search
Start Over
Supplementary Table 3 from Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245409 (XL765), a Novel, Orally Administered PI3K/mTOR Inhibitor in Patients with Advanced Solid Tumors
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- PDF file - 89KB, Supplementary Table 3. Reduction in Phosphoinositide 3-kinase and Mammalian Target of Rapamycin Complex 1 (mTORC1)/mTORC2 Pathway Signaling in Paired Tumor Biopsies.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....08e08c2af19404fdfb9bdfb03df22689
- Full Text :
- https://doi.org/10.1158/1078-0432.22448580.v1